98%
921
2 minutes
20
Our ability to skillfully manipulate objects is supported by rapid corrective responses that are initiated when we experience perturbations that interfere with movement goals. For example, the corrective lifting response is triggered when an object is heavier than expected and fails to lift off the surface. In this situation, the absence of expected sensory feedback signalling lift off initiates, within ~ 90 ms, an increase in lifting force. Importantly, when people repeatedly lift an object that, on occasional catch trials, is heavier than expected, the gain of the corrective response, defined as the rate of force increase, adapts to the 'catch' weight. In the present study, we investigated whether this response adaption transfers intermanually. In the training phase, participants used either their left or right hand (counterbalanced) to repeatedly lift a 3 N object that unexpectedly increased to 9 N on catch trials, leading to an increase in the gain of the lifting response across catch trials. Participants then lifted the object with their other hand. On the first catch trial, the gain remained elevated and thus transferred across the hands. This finding suggests that the history of lifts performed by one hand updates the corrective responses for both hands.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11283509 | PMC |
http://dx.doi.org/10.1038/s41598-024-66184-w | DOI Listing |
Proc Natl Acad Sci U S A
September 2025
Vanderbilt Brain Institute, Vanderbilt University, Nashville, TN 37240.
Major depressive disorder affects millions worldwide, yet current treatments require prolonged administration. In contrast, ketamine produces rapid antidepressant effects by blocking spontaneous N-Methyl-D-Aspartate (NMDA) receptor signaling, which lifts the suppression of protein synthesis and triggers homeostatic synaptic plasticity. Here, we identify a parallel signaling pathway involving metabotropic glutamate receptor 5 (mGluR5) that promotes rapid antidepressant-like effects.
View Article and Find Full Text PDFFront Immunol
September 2025
Department of Dermatology, The National Center for the Integration of Traditional Chinese and Western Medicine, China-Japan Friendship Hospital, Beijing, China.
Background: Bullous Pemphigoid (BP) is caused by a predominantly Th2-mediated attack on the basement membrane by the production of anti-BP180 and anti-BP230 antibodies. Malignant tumors can exacerbate immune disorders through a variety of potential pathways, including pro-inflammatory responses in the tumor microenvironment, cross-immune responses induced by tumor-associated antigens, and the lifting of immunosuppressive states and activation of underlying autoimmune responses after surgery. Alopecia Areata (AA) is an autoimmune disease caused by T-lymphocyte-mediated destruction of the immune privilege of the hair follicle, specifically involving the immune axes of Th1, Th2 and Th17.
View Article and Find Full Text PDFJ Pain
September 2025
Cyber-physical Health and Assistive Robotics Technologies Research Group, University of Nottingham, United Kingdom; School of Computer Science, University of Nottingham, Nottingham, United Kingdom.
Neck pain is among the most prevalent musculoskeletal conditions worldwide. The underlying cause mostly remains unidentified, classified as non-specific neck pain. Pain can alter movement patterns and physiological responses, suggesting that certain biomechanical and physiological changes may serve as objective biomarkers for non-specific neck pain.
View Article and Find Full Text PDFPeerJ
September 2025
Romanian-American University, Bucharest, Romania.
Background: This study aims to assess the resistance level of beginner bodybuilders of mature and elderly age to strength training performed under anaerobic energy supply modes (creatine phosphokinase and glycolysis).
Methods: The study involved 60 men who had been engaged in bodybuilding for only 12 months. Group A included men aged 24 ± 1.
J Infect
August 2025
The Francis Crick Institute, NW1 1AT London, UK; National Institute for Health Research (NIHR) University CollegeLondon Hospitals (UCLH) Biomedical Research Centre and NIHR UCLH Clinical Research Facility, UK; Research Department of Infection, Division of Infection and Immunity, University College
Background: In 2021, the rapid rollout of two doses of SARS-CoV-2 vaccines reduced COVID-19 severity and mortality. However, further vaccine doses as a prime-boost schedule were limited, and lifting of public health restrictions by late 2021 frequently led to infection, rather than vaccine, as a third exposure.
Objective: To compare how the third exposure through mRNA booster or SARS-CoV-2 infection shapes humoral and cellular immunity following two vaccine doses.